SCHEMBL7873896

SCHEMBL7873896

COC([C]=O)(c1ccccc1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
KMT2A Q03164 2/20 0.46
KDM4E B2RXH2 2/20 0.46
GAA P10253 1/20 0.46
MEN1 O00255 1/20 0.46
CES1 P23141 1/20 0.42
KCNN4 O15554 4/20 0.42
MAPK1 P28482 1/20 0.39
CHRM2 P08172 1/20 0.38
CHRM3 P20309 1/20 0.38
ALOX15 P16050 2/20 0.37
CYP3A4 P08684 2/20 0.35
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
MAPT P10636 2/20 0.34
LMNA P02545 2/20 0.34
TSHR P16473 2/20 0.33
CYP2C19 P33261 2/20 0.33
HIF1A Q16665 2/20 0.33
MAP2K7 O14733 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7870261 0.78 MEN1 (0.40) KMT2AMEN1MAPK1CYP3A4MAPT
SCHEMBL1229735 0.77 CES1 (0.42) ALDH1A1KMT2AKDM4EGAAMEN1
SCHEMBL9414518 0.77 ALDH1A1 (0.46) ALDH1A1KMT2AKDM4EGAAMEN1
SCHEMBL4080316 0.76 MAPK1 (0.43) ALDH1A1KMT2AKDM4EGAAMEN1
SCHEMBL6826582 0.76 MAPK1 (0.43) ALDH1A1KMT2AKDM4EGAAMEN1
SCHEMBL10780197 0.75 KCNN4 (0.41) ALDH1A1KMT2AKDM4EMEN1CES1
SCHEMBL4080546 0.74 KCNN4 (0.44) ALDH1A1KMT2AKDM4EGAAMEN1
SCHEMBL4085558 0.74 CES1 (0.40) ALDH1A1KMT2AKDM4EGAAMEN1
SCHEMBL9698748 0.74 CES1 (0.44) ALDH1A1KMT2AKDM4EGAAMEN1
SCHEMBL11122765 0.71 CES1 (0.41) ALDH1A1KMT2AKDM4EGAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6329502-B1 VIRICIDES AGAINST HUMAN IMMUNODEFICIENCY VIRUS; TREATMENT OF AIDS (ACQUIRED IMMUNE DEFICIENCY SYNDROME) JAPAN ENERGY CORPORATION (JP) 2001-12-11 US disclosed
US-6313094-B1 COMPOSITION FOR INHIBITING HUMAN IMMUNODEFICIENCY VIRUS REPLICATION JAPAN ENERGY CORPORATION (JP) 2001-11-06 US disclosed
EP-0490667-B1 HIV protease inhibitors JAPAN ENERGY CORP (JP) 1999-06-09 EP disclosed
EP-0490667-A2 HIV protease inhibitors JAPAN ENERGY CORPORATION (JP) 1992-06-17 EP disclosed